RXDX

Prometheus Biosciences, Inc. Common Stock

Delisted

RXDX was delisted on the 15th of June, 2023.

103 hedge funds and large institutions have $1.04B invested in Prometheus Biosciences, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 27 increasing their positions, 30 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
103
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.38M
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$64.7M
2 +$20.6M
3 +$10.7M
4
Goldman Sachs
Goldman Sachs
New York
+$9.8M
5
Marshall Wace
Marshall Wace
United Kingdom
+$9.32M

Top Sellers

1 -$27.6M
2 -$19.3M
3 -$19.1M
4
O
OrbiMed
New York
-$9.88M
5
HA
HHLR Advisors
Cayman Islands
-$7.91M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$122M
2
$104M
3
$92.2M
4
$81.5M
5
$69.8M
6
$68.9M
7
$64.7M
8
$59.9M
9
$45.4M
10
$37.3M
11
$33.5M
12
$23.6M
13
$20M
14
$17M
15
$16.3M
16
$14.5M
17
$12.4M
18
$11.4M
19
$11.2M
20
$9.44M
21
$9.32M
22
$9.25M
23
$8.72M
24
$8.56M
25
$7.06M